Frequently Relapsing Crohn's Disease Is Characterized by Persistent Elevation in Interleukin-6 and Soluble Interleukin-2 Receptor Serum Levels During Remission
Van Kemseke, Catherine; Belaiche, Jacques; Louis, Edouard
2000 • In International Journal of Colorectal Disease, 15 (4), p. 206-10
[en] We examined immune and inflammatory activation during remission in patients with Crohn's disease who presented with various clinical profiles (prolonged remission vs. relapsing disease). Thirty-six patients with at least 3 years' follow-up starting from a remission period were studied retrospectively. Relapses were defined by a retrospective calculation of the Crohn's disease activity index or by the clinical judgement of the physicians in charge of the patients. Disease course over the study period was assessed by the mean number of annual relapses. Analysis used measurements during remission of the following: erythrocytes sedimentation rate, relative lymphocytosis, acid alpha1-glycoprotein, interleukin-6 (IL-6), and soluble interleukin-2 receptor (sIL-2R) serum levels. During the study period 21 patients experienced at least one relapse and 15 did not. Mean serum levels of sIL-2R and mean relative lymphocytosis in remission significantly discriminated between relapsing and nonrelapsing patients. Only the mean sIL-2R serum level was selected by multivariate analysis, with a cutoff value of 82 pM/1 (sensitivity of 76% and specificity of 80%). The only features correlated with mean number of annual relapses in the relapsing patients were mean serum levels of sIL-2R (r=0.58, P=0.015) and IL-6 in remission (r=0.45, P=0.039). Multivariate analysis demonstrated statistical significance only for the mean serum level of IL-6 (P=0.014). In Crohn's disease the persistent elevation in sIL-2R serum levels during remission corresponds to chronic active disease, while high serum levels of IL-6 in these patients is associated with a high frequency of relapse.
Disciplines :
Gastroenterology & hepatology
Author, co-author :
Van Kemseke, Catherine ; Centre Hospitalier Universitaire de Liège - CHU > Gastro-Entérologie-Hépatologie
Belaiche, Jacques ; Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie
Louis, Edouard ; Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie
Language :
English
Title :
Frequently Relapsing Crohn's Disease Is Characterized by Persistent Elevation in Interleukin-6 and Soluble Interleukin-2 Receptor Serum Levels During Remission
Campbell C.A., Walker-Smith J.A., Hindocha P. (1982) Acute phase proteins in chronic inflammatory bowel disease in childhood. J Pediatr Gastroenterol Nutr 1:193-200.
Vesparget H., Biemond I., Waterman J. (1984) Biochemical parameters as activity index in Crohn's disease., International Congress of Gastroenterology, Lisbon, (abstract); 298.
Williams A.J.K., Symons J.A., Watchet K., Duff G.W. (1992) Soluble interleukin-2 receptor and disease activity in Crohn's disease. J Autoimmun 5:251-259.
Louis E., Belaiche J., Van Kemseke C., Schaaf N., Mathieu P., Mary J.Y. (1995) Soluble interleukin-2 receptor in Crohn's disease. Assessment of disease activity and prediction of relapse. Dig Dis Sci 40:1750-1756.
Holtkamp W., Stollberg T., Reis H.E. (1995) Serum interleukin-6 is related to disease activity but not disease specificity in inflammatory bowel disease. J Clin Gastroenterol 20:123-126.
Louis E., Van Kemseke C., De Groote D., Franchimont D., Belaiche J. (1994) IL-6, TNF-α and soluble TNF-α receptor serum levels in Crohn's disease. Gut , (abstract); 35(SUPPL. 4).
Louis E., Belaiche J., Van Kemseke C., Franchimont D., De Groote D., Gueenen V., Mary J.Y. (1997) A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. Eur J Gastroenterol Hepatol 9:939-944.
Brignola C., Campieri M., Bazzocchi G., Farrugia P., Tragone A., Lafranchi G.A. (1986) A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterology 91:1490-1494.
Andre C., Descos L., Vignal J., Gillon J. (1983) C-reactive protein as predictor of relapses in asymptomatic patients with Crohn's disease. Scott Med J 28:26-29.
Schreiber S., Nikolaus S., Hampe J., Hamling J., Koop I., Groessner B., Lochs H., Raedler A. (1999) Tumor necrosis factor alpha and interleukin 1 beta in relapse of Crohn's disease. Lancet 353:459-461.
Best W.R., Becktel J.M., Singelton J.W., Kern F. (1976) Development of a Crohn's disease activity index: National Co-operative Crohn's Disease Study. Gastroenterology 70:439-444.
Modigliani R., Mary J.Y., Simon J.F., Cortot A., Soule J.C., Gendre J.P., Rene E. (1990) The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives Clinical, biological and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Gastroenterology 98:811-818.
Wyatt J., Vogelsgang H., Hubl W., Waldohoer, Lochs H. (1993) Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 341:1437-1439.
Brignola C., Iannone P., Belloli C., De Simone G., Bassein L., Gionchetti P., Belluzzi A., Campieri M., Barbara L. (1994) Prediction of relapse in patients with Crohn's disease in remission: A simplified index using laboratory tests, enhanced by clinical characteristics. Eur J Gastroenterol Hepatol 6:955-961.
Rubin L.A., Nelson D.L. (1990) The soluble interleukin-2 receptor: Biology, function and clinical application. Ann Intern Med 113:619-627.
Matsuura T., West G.A., Klein J.S., Ferraris L., Fiocchi C. (1992) Soluble interleukin 2 and CD8 and CD4 receptors in inflammatory bowel disease. Gastroenterology 102:2006-2014.
Mahida Y.R., Gallagher A., Kurlak L., Hawkey C.J. (1990) Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease. Clin Exp Immunol 82:75-80.
Brynskov, Tvede N. (1990) Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin. Gut 31:795-799.
Mueller C., Knoflach P., Zielinski C.C. (1990) T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells. Gastroenterology 98:639-646.
Heimann T., Aufses A. (1985) The role of peripheral lymphocytes in the prediction of recurrence in Crohn's disease. Surg Gynecol Obstet 160:295-298.
Hirano T. (1991) Interleukin-6., ThomsonA(ed) The cytokine handbook. Academic, London; 241-256.
Kusugami K., Fukatsu A., Tanimoto M., Shinoda M., Haruta J.I., Kuroiwa A., Ina K., Kanayama K., Ando T., Matsuura T., Yamaguchi T., Morise K., Ieda M., Iokawa H., Ishihara A., Sarai S. (1995) Elevation on interleukin-6 in inflammatory bowel disease is macrophageand epithelial cell-dependent. Dig Dis Sci 40:949-959.
Stevens C., Walz G., Singaram C., Lipman M., Zanker B., Muggia A., Antonioli D., Peppercorn M.A., Strom T.B. (1992) Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 37:818-826.
Reinecker H.C., Steffen M., Witthoeft T., Pflueger I., Schreiber S., MacDerrmot R.P., Raedler A. (1993) Enhanced secretion of tumour necrosis factor alpha, IL-6, and IL-1 beta isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94:174-181.
Gross V., Andus T., Caesar I., Roth M., Schomerlich J. (1992) Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology 102:514-519.
